Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p53 mutation in squamous cell carcinomas from psoriasis patients treated with psoralen + UVA (PUVA).

The Journal of investigative dermatology - 1 Aug 1997

Nataraj A J, Wolf P, Cerroni L, Ananthaswamy H N

Abstract excerpt

Individuals suffering from psoriasis are treated with a combination of psoralen and UVA radiation, commonly referred to as "PUVA" therapy. Epidemiologic studies have shown that PUVA therapy is a risk factor for skin cancer in psoriasis patients. Although PUVA treatment induces skin cancer in labo...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Squamous Cell
Share to Genes, p53
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polymorphism, Single-Stranded Conformational

Share to Psoriasis

Share to Skin Neoplasms

Source

Identifiers

PMID: 9242514
DOI: 10.1111/1523-1747.ep12319764

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-9242514-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p53 mutation in squamous cell carcinomas from psoriasis patients treated with psoralen + UVA (PUVA).PMID 9242514Read ↗

An unexpected spectrum of p53 mutations from squamous cell carcinomas in psoriasis patients treated with PUVA.Semantic proximity Read ↗

High mutation frequency at Ha-ras exons 1-4 in squamous cell carcinomas from PUVA-treated psoriasis patients.Semantic proximity Read ↗

p53 mutations experimentally induced by 8-methoxypsoralen plus UVA (PUVA) differ from those found in human skin cancers in PUVA-treated patients.Semantic proximity Read ↗

High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralen-plus-ultraviolet-A-treated psoriasis patients.Semantic proximity Read ↗

Ultraviolet Exposure as the Main Initiator of p53 Mutations in Basal Cell Carcinomas from Psoralen and Ultraviolet A-Treated Patients with PsoriasisSemantic proximity Read ↗

p53 mutation in nonmelanoma skin cancers occurring in psoralen ultraviolet a-treated patients: evidence for heterogeneity and field cancerization.Semantic proximity Read ↗

p53 tumor suppressor gene: a critical molecular target for UV induction and prevention of skin cancer.Semantic proximity Read ↗

p53 mutations as a marker of skin cancer risk: comparison of UVA and UVB effects.Semantic proximity Read ↗

p53 gene mutations in SKH-1 mouse tumors differentially induced by UVB and combined subcarcinogenic benzo[a]pyrene and UVA.Semantic proximity Read ↗

UV-A fingerprint mutations in human skin cancer.Semantic proximity Read ↗

Inhibition of UV-induced p53 mutations and skin cancers by sunscreens: implication for skin cancer prevention.Semantic proximity Read ↗

TP53 mutations in human skin cancers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.